Please login to the form below

Not currently logged in
Email:
Password:

MHRA chair Breckenridge to advise UK on healthcare ethics

Sir Alasdair Breckenridge appointed first chair of the Emerging Science and Bioethics Advisory Committee

Professor Sir Alasdair Breckenridge - MHRA chairChair of the UK's Medicines and Healthcare products Regulatory Agency (MHRA), Sir Alasdair Breckenridge, has been appointed the first chair of the Emerging Science and Bioethics Advisory Committee at the country's Department of Health (DH).

The new committee has been formed to advise UK health departments on emerging healthcare scientific developments and their ethical, legal, social and economic implications.

"I am delighted that Sir Alasdair has agreed to chair this important new committee,” said the DH's chief medical officer, Dame Sally Davies.

“He brings with him a level of experience that is difficult to match, plus a reputation for delivering high calibre debate and advice on serious scientific issues.”

In addition to his MHRA experience, Sir Alasdair's previous roles include serving as a member of the Adverse Reactions Group, and the Subcommittee on Adverse Reactions to Vaccines and Immunisation of the MHRA precursor, the Committee on Safety of Medicines (CSM).

Between 1992 and 1996 he was a member of the Medical Research Council, and he has worked closely on several programmes of the European Union, the World Health Organization and the International Union of Pharmacology.

Sir Alasdair takes up the position immediately, and will remain in the role for two years while also serving for the MHRA.

23rd May 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
VCCP Health

We’re the challenger agency for challenger brands. Brands with a point to prove. Rx, OTC and wellness brands run by...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics